These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21406057)

  • 1. Challenges for the development of new treatments for severe asthma: a pharmaceutical perspective.
    Knowles RG
    Curr Pharm Des; 2011; 17(7):699-702. PubMed ID: 21406057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novelty in the target landscape of the pharmaceutical industry.
    Agarwal P; Sanseau P; Cardon LR
    Nat Rev Drug Discov; 2013 Aug; 12(8):575-6. PubMed ID: 23903214
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal antibodies for chronic refractory asthma and pipeline developments.
    Polosa R; Casale T
    Drug Discov Today; 2012 Jun; 17(11-12):591-9. PubMed ID: 22306350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in risks associated with new drug development: success rates for investigational drugs.
    DiMasi JA; Feldman L; Seckler A; Wilson A
    Clin Pharmacol Ther; 2010 Mar; 87(3):272-7. PubMed ID: 20130567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. U-BIOPRED: evaluation of the value of a public-private partnership to industry.
    Riley JH; Erpenbeck VJ; Matthews JG; Holweg CTJ; Compton C; Seibold W; Higenbottam T; Wagers S; Rowe A; Myles D;
    Drug Discov Today; 2018 Sep; 23(9):1622-1634. PubMed ID: 29936248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buy buy bispecific antibodies.
    Holmes D
    Nat Rev Drug Discov; 2011 Oct; 10(11):798-800. PubMed ID: 22037028
    [No Abstract]   [Full Text] [Related]  

  • 7. Moving from an asthma pipe dream to a pipeline.
    Holmes D
    Nat Rev Drug Discov; 2012 Oct; 11(10):737-8. PubMed ID: 23023668
    [No Abstract]   [Full Text] [Related]  

  • 8. To make better therapeutics, companies strive to increase the content of results and get them faster.
    Szpir M
    Biotechniques; 2007 Apr; 42(4 Suppl):S3-5. PubMed ID: 18798735
    [No Abstract]   [Full Text] [Related]  

  • 9. Vas Narasimhan.
    Narasimhan V; Mullard A
    Nat Rev Drug Discov; 2016 Jan; 15(1):10-1. PubMed ID: 26718275
    [No Abstract]   [Full Text] [Related]  

  • 10. Q&A: Bernard Munos.
    Bender E
    Nature; 2016 May; 533(7602):S59. PubMed ID: 27167392
    [No Abstract]   [Full Text] [Related]  

  • 11. 2011 in reflection.
    Mullard A
    Nat Rev Drug Discov; 2012 Jan; 11(1):6-8. PubMed ID: 22212664
    [No Abstract]   [Full Text] [Related]  

  • 12. [Open innovation for Japanese pharmaceutical companies].
    Hoshino T
    Nihon Yakurigaku Zasshi; 2013 Oct; 142(4):184-9. PubMed ID: 24107523
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibiotics in late clinical development.
    Fernandes P; Martens E
    Biochem Pharmacol; 2017 Jun; 133():152-163. PubMed ID: 27687641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinued drugs in 2010: oncology drugs.
    Williams R
    Expert Opin Investig Drugs; 2011 Nov; 20(11):1479-96. PubMed ID: 21955127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bitter pill.
    Nat Chem; 2010 May; 2(5):337. PubMed ID: 20414223
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug Development and Biologics in Asthma. A New Era.
    Doyle R
    Ann Am Thorac Soc; 2016 Mar; 13 Suppl 1():S83-4. PubMed ID: 27027958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ian Tomlinson.
    Tomlinson I
    Nat Rev Drug Discov; 2016 Mar; 15(3):154. PubMed ID: 26893183
    [No Abstract]   [Full Text] [Related]  

  • 18. Emerging Biologics in Severe Asthma.
    Pavord ID; Hilvering B; Shrimanker R
    Immunol Allergy Clin North Am; 2016 Aug; 36(3):609-23. PubMed ID: 27401629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stratified approaches to the treatment of asthma.
    Holgate ST
    Br J Clin Pharmacol; 2013 Aug; 76(2):277-91. PubMed ID: 23163316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileukotrienes, asthma pathogenesis and the pharmaceutical industry.
    O'Byrne PM
    CMAJ; 1999 Jan; 160(2):209-10. PubMed ID: 9951442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.